August 7, 2007; CHINDEX INTERNATIONAL ANNOUNCES DA VINCIĀ® S" SYSTEM CONTRACT IN HONG KONG; Queen Mary Hospital will be Chindexs Fourth Intuitive Surgical Installation in Greater China
  Home »News »Press Release

Bethesda, Maryland - October 29, 2004 - Chindex International, Inc. (NASDAQ:CHDX), an independent American provider of Western healthcare products and medical services in the People's Republic of China, today announced the appointment of A. Kenneth Nilsson as the Company's Chairman of the Board of Directors, a position previously held by Roberta Lipson, who will continue as President and CEO. Mr. Nilsson has been an independent member of the Board since January 1996 and will continue to serve as Chairman on that basis.


"Ken's experience and leadership have been invaluable assets to Chindex for many years now. We have taken this step to further strengthen the independence of the Board and proactively respond to the sprit of new standards for corporate governance of public companies," Lipson said.


Mr. Nilsson also serves as Chairman of the Company's Audit Committee. He formerly served as President of Cooper Laboratories, Inc.; President of Cooper Lasersonics, Inc.; Managing Director of Pfizer Taito Ltd.; President of Max Factor, Japan; and Chairman of the Monterey Institute of International Studies . Mr. Nilsson received a B.A. degree from the University of Southern California and an M.A. degree from the University of California .


Company Profile

Chindex is an American company operating in several healthcare sectors of the Chinese marketplace, including Hong Kong . It provides representative and distribution services to a number of major multinational companies including Siemens AG (ultrasound systems), and Guidant (interventional cardiology products including stents, balloon catheters and guide wires). Its distribution channels to the retail pharmacy industry in China have been developed through a relationship with a major multinational cosmetics manufacturer. It also provides healthcare services through the operations of its private hospital corporation in China . With twenty-three years of experience, over 800 employees, and operations in the United States , China and


Hong Kong , the Company's strategy is to expand its cross-cultural reach by providing leading edge

technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, and .


The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties pertaining to the Company's (i) successful marketing and distribution of new products, (ii) performance goals, including successful conclusion of efforts to secure government-backed financing, (iii) future events and earnings, including revenues from the Company's developmental businesses such as healthcare services, (iv) markets, including growth in demand in China for the Company's products and services, and (v) proposed new operations, including expansion of its healthcare services business. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


# # #




Copyright © 2002 Chindex International, Inc. All Rights Reserved